Steven Cohen’s Adverum Biotechnologies ADVM Stock Holding History

Steven Cohen’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15,840	Closed	-$1.56M	–	950
2021 Q1	$1.56M	Buy	+15,840	New	+$1.9M	0.01%	760

Other funds holding ADVM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Steven Cohen's ADVM Position: Q2 2019 in Review

Steven Cohen sold out of Adverum Biotechnologies (ADVM) in Q2 2019, closing a stake of 40,000 shares — an estimated $2.1M sold.

Steven Cohen first reported a position in ADVM in Q4 2018 and held it in 2 quarters. The position peaked at $2.1M in Q1 2019. 94 funds tracked by Wall St. Rank hold ADVM as of Q2 2019.

Steven Cohen reported no remaining Adverum Biotechnologies position as of Q2 2019 after selling out during the quarter.
Steven Cohen sold 40,000 Adverum Biotechnologies shares in Q2 2019, an estimated $2.1M.
Steven Cohen first reported a position in Adverum Biotechnologies in Q4 2018 and held it in 2 quarters.
Steven Cohen's Adverum Biotechnologies position peaked at $2.1M in Q1 2019.
94 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2019.

Based on Point72 Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.